Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05356793
PHASE2
The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
Sponsor: Sacsh
View on ClinicalTrials.gov
Summary
The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.
Official title: A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2021-03-01
Completion Date
2022-03-28
Last Updated
2026-04-14
Healthy Volunteers
No
Interventions
DRUG
SCH-1
Novel anti-infective eyedrop
DRUG
Placebo
SCH-1 vehicle minus active components eyedrop
Locations (1)
Jacqueline Dauhajre, MD
Jackson Heights, New York, United States